The formulation centres on two active substances: N-acetyl-D-glucosamine (NAG) and undenatured type II collagen (UC-II®), both of which are presented in effective, science-backed doses. NAG may stimulate hyaluronic acid production, according to in vitro studies, supporting cartilage hydration and resilience. It has also been linked to positive effects on cartilage metabolism, particularly in populations showing early degeneration.

UC-II®, derived from chicken cartilage, is included in a low dose (40 mg/day) consistent with studies showing its ability to reduce joint stiffness and pain in individuals with osteoarthritis. Thanks to a patented low-temperature, non-enzymatic manufacturing process, UC-II® retains its natural triple helical structure.

Together, the two ingredients act synergistically to contribute to daily joint comfort and flexibility. Their recognised roles in maintaining joint and cartilage health are confirmed by Korean health claims, further supporting the product’s credibility. Dosages align with those identified in the scientific literature as effective, reinforcing the product’s functional integrity.

The label is presented with clarity and restraint, listing the quantities of active ingredients in a transparent and user-friendly format. The communication avoids overstatement while providing sufficient information for informed use. In recognition of its quality, this supplement has earned a place among the nominees for the 2025 Jury Prize.